Drug‐Induced Sialolithiasis—A Big‐Data Retrospective Study
Oral Diseases · 2026-09 · 32 (9) · 2784-2790
DOI: 10.1111/odi.70366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 10.06.2026. Verfasst von Gal Avishai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Rabin Medical Centre, Petach-Tikva, Israel. Hauptthemen laut MEDLINE: Salivary Gland Calculi. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Sialolithiasis pathophysiology is multifactorial, with systemic medications often hypothesised as a key contributor, particularly in older adults (Drug‐Induced Sialolithiasis). However, robust evidence supporting this theory is limited. This study aimed to investigate the association between common medication classes and sialolithiasis in an older Israeli cohort.
Methods
A nationwide retrospective case–control study (2005–2024) was conducted using the Clalit Health Services database. Sialolithiasis cases were matched 1:3 with controls based on age and gender. After stratification using a Gaussian Mixture Model (age > 50.28 years), logistic regression analyses assessed the association between sialolithiasis and antihyperlipidemic, antihypertensive, psychiatric, neurologic and antidiabetic medications. Significance was considered under p ‐value of 0.05.
Results
The cohort included 32,088 individuals (8015 cases). Multivariable analysis revealed significantly increased odds of sialolithiasis associated with neurologic (OR 1.31, p < 0.001), antihyperlipidemic (OR 1.18, p < 0.001), psychiatric (OR 1.16, p < 0.001) and antihypertensive medications (OR 1.08, p = 0.016). Antidiabetics showed no significant association.
Conclusions
This large‐scale analysis strongly supports the theory of Drug‐Induced Sialolithiasis. The independent association between these four common medication classes and increased odds of sialolithiasis in older adults suggests that medication‐induced hyposalivation is a major, quantifiable risk factor in the aetiology of the condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Rabin Medical Centre, Petach-Tikva, Israel.
- Department of Oral and Maxillofacial Surgery, The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel.
- Faculty of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel.
- Department of Oral Medicine and Radiology, King George's Medical University, Lucknow, India.
ORCID-Profile: Gal Avishai, Akhilanand Chaurasia, Gavriel Chaushu, Daya Masri
Zitieren
APA
Avishai, G., Caspi, G., Chaurasia, A., Chaushu, G., Masri, D., & Jonas, E. (2026). Drug‐Induced Sialolithiasis—A Big‐Data Retrospective Study. Oral Diseases, 32(9), 2784-2790. https://doi.org/10.1111/odi.70366
Vancouver
Avishai G, Caspi G, Chaurasia A, Chaushu G, Masri D, Jonas E. Drug‐Induced Sialolithiasis—A Big‐Data Retrospective Study. Oral Diseases. 2026;32(9):2784-2790. doi:10.1111/odi.70366
BibTeX
@article{Avishai2026,
author = {Avishai, Gal and Caspi, Gil and Chaurasia, Akhilanand and Chaushu, Gavriel and Masri, Daya and Jonas, Ehud},
title = {Drug‐Induced Sialolithiasis—A Big‐Data Retrospective Study},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {9},
pages = {2784--2790},
doi = {10.1111/odi.70366}
}
EUVIMED